Decentralized clinical trials (DCTs) have emerged as a transformative paradigm within the United States clinical research ecosystem, driven by advances in digital health technologies, regulatory flexibility, and the need to enhance patient-centricity. This review proposes a comprehensive analytics-driven framework designed to optimize patient recruitment, retention, and data integrity in hybrid clinical trial designs that integrate both decentralized and site-based elements. The study synthesizes existing literature on digital trial infrastructures, real-world data integration, and predictive analytics to construct a unified model tailored to U.S. regulatory, technological, and demographic contexts. The proposed framework emphasizes the use of advanced data analytics, including machine learning–based patient matching algorithms, real-time engagement monitoring systems, and risk-based data quality assurance mechanisms. By leveraging electronic health records (EHRs), wearable device data, and mobile health applications, the framework enables dynamic identification of eligible participants, thereby addressing persistent recruitment bottlenecks and improving population diversity. Furthermore, retention strategies are enhanced through behavioral analytics, personalized communication protocols, and adaptive intervention models that respond to patient engagement patterns in real time. A critical component of the framework is its focus on data integrity within decentralized environments. The integration of blockchain-enabled audit trails, automated anomaly detection systems, and regulatory-compliant data governance structures ensures the reliability, traceability, and security of clinical data. The review also evaluates the role of U.S. regulatory bodies, such as the FDA, in shaping guidelines for decentralized trials, emphasizing the need for standardized validation protocols and interoperability frameworks. Through a systematic examination of current methodologies and emerging technologies, this study provides a structured approach for implementing analytics-driven decentralized clinical trials. The findings highlight the potential of hybrid trial models to reduce operational costs, accelerate study timelines, and improve clinical outcomes while maintaining rigorous data quality standards. The proposed framework offers practical insights for researchers, sponsors, and policymakers seeking to advance the efficiency and inclusivity of clinical research in the evolving digital health landscape.
Ifiala Agwu Ifiala*1, Onuh Matthew Ijiga2, Emmanuel Igba3 (Tue,) studied this question.